USpolicy

News

Johnson & Johnson is the latest pharma group to agree a Most-Favoured Nation (MFN) drug pricing deal with the Trump administration to avert tariffs.

News

Hospitals that challenged a US pilot of a new rebate model for medicines provided to low-income people have won another legal victory.

News

The CDC has upended the childhood vaccination schedule, cutting the number of recommended shots in a move that has dismayed medical organisations.

News

A federal judge in the US has granted a restraining order that will stop the 340B rebate model from launching as planned on 1st January.

News

CMS unveils two more programmes in the Trump administration's efforts to cut drug prices, which have not been well received by the pharma industry.

News

Nine more pharma groups have agreed to lower the costs of medicines in the US under the Trump administration's most favoured nation (MFN) scheme.